Get 40% Off
🎁 Free Gift Friday: Copy Legendary Investors' Portfolios in One ClickCopy for Free

Obama Government Seeks Legislation To Curb Corporate Tax Flight

Published 07/16/2014, 02:54 AM
Updated 07/16/2014, 03:15 AM
Obama Government Seeks Legislation To Curb Corporate Tax Flight

By Avaneesh Pandey - The Barack Obama administration on Tuesday called for immediate legislation to prevent U.S.-based companies from re-incorporating overseas for lower taxes, the Wall Street Journal reported Tuesday.

Treasury Secretary Jacob Lew wrote a letter to Senate Financing Committee Chairman Ron Wyden on Tuesday and called for a “new sense of economic patriotism," urging Congress to clamp down on the "abuse of our tax system." He also stated that U.S.-based companies should not be allowed to indulge in “inversion” transactions solely for the purpose of changing their tax status.

The White House had earlier proposed similar steps in the budget and called for broad reforms in corporate taxation. In his letter, Lew added that the “President had called for undertaking business tax reforms as a way of improving the investment climate in the U.S.” He also stated that there was a need to lower the corporate tax rate in the country to make the investment climate in the country more "business-friendly."

Many companies seek to reduce their tax burden by relocating to countries with a lower tax rate. They do so by either buying another company in the target country and adopting its domicile, or by establishing a new company in the target country. This process, known as “inversion,” has been popular among many pharmaceutical companies in the U.S., which have overseas cash they don’t want to subject to the 35 percent corporate tax rate prevalent in the U.S., which is the highest in the world.

In his letter, Lew also demanded that a legislation to limit corporate tax inversions be implemented retroactively from May.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

It isn’t yet clear whether the Obama administration is targeting inversion deals that were signed before but not closed by May, or only deals agreed upon since then. Such a law would apply to U.S drug maker AbbVie Inc's (NYSE:ABBV) deal with Ireland-based Shire Plc (NASDAQ:SHPG) and Mylan Inc's (NASDAQ:MYL) pending deal for Abbott Laboratories' (NYSE:ABT) overseas generics business.

Fearing unfavorable legislation, many companies have reportedly been adding clauses to merger agreements that would allow them to walk away without paying a penalty if the tax advantage is suddenly taken away. About 50 U.S. firms have reincorporated overseas through inversions in the last 10 years, the Journal reported.

Another report from the Journal, citing the findings of a Congressional research panel, stated that the U.S. would have received an additional $20 billion over the past decade through corporate taxes, if inversions had not taken place.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.